Literature DB >> 25344600

SAMHD1 expression in blood cells of HIV-1 elite suppressors and viraemic progressors.

Erin L Buchanan1, Melissa A McAlexander1, Kenneth W Witwer2.   

Abstract

Entities:  

Keywords:  IFN; PBMCs; elite controllers; interferon

Mesh：

Substances：

Year:  2014        PMID： 25344600      PMCID： PMC4319484          DOI： 10.1093/jac/dku428

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Increased expression of SAMHD1 in a subset of HIV-1 elite controllers.

Authors:  Eva Riveira-Muñoz; Alba Ruiz; Eduardo Pauls; Marc Permanyer; Roger Badia; Beatriz Mothe; Manel Crespo; Bonaventura Clotet; Christian Brander; Ester Ballana; José A Esté
Journal:  J Antimicrob Chemother       Date:  2014-07-25       Impact factor: 5.790

2.  GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state.

Authors:  Erik C Hansen; Kyle J Seamon; Shannen L Cravens; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

3.  Cloning and characterization of a novel cDNA that is IFN-gamma-induced in mouse peritoneal macrophages and encodes a putative GTP-binding protein.

Authors:  W P Lafuse; D Brown; L Castle; B S Zwilling
Journal:  J Leukoc Biol       Date:  1995-03       Impact factor: 4.962

4.  Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1.

Authors:  Alexandra Cribier; Benjamin Descours; Ana Luiza Chaves Valadão; Nadine Laguette; Monsef Benkirane
Journal:  Cell Rep       Date:  2013-04-17       Impact factor: 9.423

5.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Anh Nguyen; Baek Kim; Marina Tuzova; Felipe Diaz-Griffero
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

Review 6.  The implications of viral reservoirs on the elite control of HIV-1 infection.

Authors:  Robert W Buckheit; Maria Salgado; Karen O Martins; Joel N Blankson
Journal:  Cell Mol Life Sci       Date:  2012-08-04       Impact factor: 9.261

7.  SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons.

Authors:  Corine St Gelais; Suresh de Silva; Sarah M Amie; Christopher M Coleman; Heather Hoy; Joseph A Hollenbaugh; Baek Kim; Li Wu
Journal:  Retrovirology       Date:  2012-12-11       Impact factor: 4.602

8.  Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.

Authors:  Kenneth W Witwer; Andria K Watson; Joel N Blankson; Janice E Clements
Journal:  Retrovirology       Date:  2012-01-12       Impact factor: 4.602

9.  miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction.

Authors:  Jeanne M Sisk; Janice E Clements; Kenneth W Witwer
Journal:  Viruses       Date:  2012-09-25       Impact factor: 5.048

10.  Expression profile of host restriction factors in HIV-1 elite controllers.

Authors:  Mohamed Abdel-Mohsen; Rui André Saraiva Raposo; Xutao Deng; Manqing Li; Teri Liegler; Elizabeth Sinclair; Mohamed S Salama; Hussam El-Din A Ghanem; Rebecca Hoh; Joseph K Wong; Michael David; Douglas F Nixon; Steven G Deeks; Satish K Pillai
Journal:  Retrovirology       Date:  2013-10-16       Impact factor: 4.602
  10 in total
  7 in total

1.  Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.

Authors:  Roger Badia; Guillem Angulo; Eva Riveira-Muñoz; Maria Pujantell; Teresa Puig; Cristina Ramirez; Javier Torres-Torronteras; Ramón Martí; Eduardo Pauls; Bonaventura Clotet; Ester Ballana; José A Esté
Journal:  J Antimicrob Chemother       Date:  2015-11-04       Impact factor: 5.790

2.  Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients.

Authors:  Maura Statzu; Letizia Santinelli; Agnese Viscido; Claudia Pinacchio; Giancarlo Ceccarelli; Claudia Rotondo; Giuseppe Corano Scheri; Ivano Mezzaroma; Ombretta Turriziani; Guido Antonelli; Gabriella d'Ettorre; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2018-12-18       Impact factor: 4.148

3.  Immune Activation Influences SAMHD1 Expression and Vpx-mediated SAMHD1 Degradation during Chronic HIV-1 Infection.

Authors:  Weihui Fu; Chao Qiu; Mingzhe Zhou; Lingyan Zhu; Yu Yang; Chenli Qiu; Linxia Zhang; Xuan Xu; Ying Wang; Jianqing Xu; Xiaoyan Zhang
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

4.  Increased expression of CDKN1A/p21 in HIV-1 controllers is correlated with upregulation of ZC3H12A/MCPIP1.

Authors:  Suwellen S D de Azevedo; Marcelo Ribeiro-Alves; Fernanda H Côrtes; Edson Delatorre; Lucia Spangenberg; Hugo Naya; Leonardo N Seito; Brenda Hoagland; Beatriz Grinsztejn; Valdilea G Veloso; Mariza G Morgado; Thiago Moreno L Souza; Gonzalo Bello
Journal:  Retrovirology       Date:  2020-07-02       Impact factor: 4.602

Review 5.  Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.

Authors:  Marta Colomer-Lluch; Alba Ruiz; Arnaud Moris; Julia G Prado
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

6.  miRNAs and SAMHD1 regulation in vitro and in a model of HIV CNS disease.

Authors:  Kenneth W Witwer; Erin L Buchanan; Stephanie L Myers; Melissa A McAlexander
Journal:  J Neuroinflammation       Date:  2015-09-04       Impact factor: 8.322

7.  SAMHD1 transcript upregulation during SIV infection of the central nervous system does not associate with reduced viral load.

Authors:  Erin L Buchanan; Diego A Espinoza; Melissa A McAlexander; Stephanie L Myers; Adam Moyer; Kenneth W Witwer
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.